1. Market Research
  2. > Pharmaceutical

Pharmaceutical Market Research: Pharma Industry Analysis Reports

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
106 votes

Global Pharmaceutical Industry Overview

The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics.

The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics segment. Cancer is the largest segment. This was closely followed by the pain and diabetes segments with shares of 6% and 5% respectively, according to IMS.

Key Pharmaceutical International Markets

  • North America is the largest market, with revenues exceeding $340 billion.
  • This was followed by Europe with revenues of $224 billion according to IMS.
  • Emerging countries in Asia and Latin America are forecast to grow rapidly. Increase in spending in these countries will be driven by rising incidence of disease, favorable government policies and improving healthcare infrastructure (and the multiplication of drug stores and pharmacies in large cities.

Pharmaceutical Industry Key Players

Novartis is the pharmaceutical market leader (thanks to a state-of-the-art drug discovery and development department) with revenues of $51 billion and a market share of 5%. Primary contributors to its sales were the drugs Gilenya and Affinitor. Pfizer is close behind Novartis with a 4% share of the global market according to IMS.

The top ten players are forecast to collectively lose share from 35% in 2013 to 30% in 2017, according to IMS. Patent expiries over the next few years will eat into the revenues of most companies during this period.

Sanofi potential loss due to patent expiries is estimated to reach up to $8.1 billion. The company is then followed by Novartis, Roche, Astra-Zeneca and Eli Lilly with respectively potential losses of 7.7, 7.2, 6.7 and 6 billion dollars.  

Pharmaceutical Market Sales Forecast 

Pharmaceutical industry trends show that the global market is set to show steady growth in the next five years at a CAGR of 4-5%. Innovative on-prescritpion drugs and over-the-counter drugs entering the market and biologics such as targeted therapies for cancer will be key in driving growth.

Key Trends and Strategies for Growth in the Pharmaceutical Market

Four trends are shaping pharmaceutical markets.

New Government Policies are Expanding Healthcare Coverage

Expanded patient coverage is a key trend in the pharmaceutical market. China has increased its healthcare spending to $116 billion as part of its latest 12 year plan. India has created a $5 billion policy aimed at providing health services to government hospitals and clinics, especially in the rural areas. The U.S. Affordable Care Act and the U.K. Health and Social Care Act also create opportunities.

The differing nature of the policies means pharmaceutical companies must adapt their marketing strategies for each region or country. A ‘one size fits all’ strategy will no longer work.

Emerging Pharmaceutical Markets are Improving Healthcare Provision

Improving healthcare provision, increased incidence of chronic diseases, the appearance of safer drug delivery systems and medical tourism are driving pharmaceutical industries in emerging markets. Branded drugs penetration is about 25% (due to the importance of generic drugs) as compared to about 75% in developed economies, according to IMS, giving the potential for expansion in the branded sector. 

Pharmaceuticals companies should focus on these emerging markets. 

Read more »

24/7 Customer Support

Talk to Sam

0044 208 068 8943

1-10 of about 40000 reports

Global Pharmaceutical Markets - Forecast

  • June 2017
    41 pages
  • Pharmaceutical  


    Anti Rheumatic  

  • World  

    United States  

    North America  

View report >

Pharmaceutical Industry in the US - Forecast

  • June 2017
    5 pages
  • Pharmaceutical  

  • United States  

    United Kingdom  

View report >

Pharmaceutical Industry in Europe

  • June 2017
    36 pages
  • Pharmaceutical  

  • Europe  

View report >

Pharmaceutical Industry in India and Asia

  • March 2016
    79 pages
  • India  



View report >

Pharmaceutical Industry in Japan

  • April 2017
    6 pages
  • Pharmaceutical  


  • Japan  



View report >

Pharmaceutical Markets in France and Europe

  • October 2016
    20 pages
  • Pharmaceutical  

  • Europe  


View report >

The future of the Pharmaceutical Industry in Germany

  • January 2017
    16 pages
  • Pharmaceutical  

  • Germany  



View report >

Pharmaceutical Industry in Italy

  • August 2016
    76 pages
  • Pharmaceutical  


  • Italy  


View report >

Pharmaceutical Industry in the UK

  • May 2017
    15 pages
  • Pharmaceutical  

  • United Kingdom  

View report >

Pharmaceutical Industry in Canada

  • May 2017
    47 pages
  • Canada  


    North America  

View report >

About 11000 reports

Purchase Reports From Reputable Market Research Publishers
(From € 135 - € 68182)

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • € 68182
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Tumor Markers Testing Market 2021: A 74-country Analysi ...

June 2017 € 47636

Cancer Diagnostics Market 2021: A 74-country Analysis-- ...

May 2017 € 47636

Europe Clinical Chemistry Reagents And Analyzers Market ...

May 2017 € 34091

Europe Tumor Markers Testing Market 2021: A 31-country ...

June 2017 € 32727

Europe Cancer Diagnostics Market 2021: A 31-country Ana ...

May 2017 € 32727

Immunodiagnostics 2021: Supplier Shares And Strategies, ...

March 2017 € 21364

Asia-pacific Clinical Chemistry Reagents And Analyzers ...

May 2017 € 15000

Europe Cancer Diagnostics Market Analysis 2021: France, ...

June 2017 € 11636

Opportunityanalyzer: Cystic Fibrosis - Opportunity Anal ...

April 2017 € 9995

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.